Global kidney disease death rates have increased 24% from 1990 to 2021, signaling a critical health challenge that extends beyond kidney function alone. Experts now recognize a complex relationship between cardiovascular, kidney, and metabolic health that significantly impacts patient outcomes.
Medical professionals are highlighting the emerging concept of cardiovascular-kidney-metabolic (CKM) syndrome, which demonstrates how these interconnected systems influence overall health. According to Dr. Janani Rangaswami, a professor at George Washington University, kidney disease serves as a powerful risk predictor for cardiovascular complications.
Approximately one in three U.S. adults have at least three components of CKM syndrome, with early kidney damage substantially increasing cardiovascular disease risks. Studies indicate that three in five people with early-stage kidney disease also have cardiovascular conditions, underscoring the urgent need for comprehensive medical approaches.
The syndrome progresses through four stages, with early stages potentially being reversible. Notably, 90% of U.S. adults meet the criteria for stage 1, characterized by excess weight and potential insulin resistance. Risk factors include abnormal cholesterol, high blood pressure, elevated blood glucose, and type 2 diabetes.
Healthcare professionals emphasize the importance of regular screenings, including urine albumin to creatinine ratio (UACR) and estimated glomerular filtration rate (eGFR) tests. Controlling metabolic factors such as body weight, blood pressure, and glucose levels can significantly reduce cardiovascular and kidney disease risks.
The American Heart Association's Cardiovascular-Kidney-Metabolic Health Initiative aims to promote interdisciplinary care and increase awareness about these interconnected health challenges. By advocating for earlier diagnosis and integrated treatment strategies, the initiative seeks to improve patient outcomes and reduce the overall burden of chronic diseases.
